Serum FAM19A5 in newly diagnosed type 2 diabetes mellitus and its association with metabolic and inflammatory parameters

Halime Seda Küçükerdem, Giray Bozkaya, İsmail Demir

Open source

DOI
10.1097/md.0000000000050782
Published
2026-09-25
Container
Medicine
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/md.0000000000050782,
  title = {Serum FAM19A5 in newly diagnosed type 2 diabetes mellitus and its association with metabolic and inflammatory parameters},
  author = {Halime Seda Küçükerdem and Giray Bozkaya and İsmail Demir},
  year = {2026},
  journal = {Medicine},
  doi = {10.1097/md.0000000000050782},
  url = {https://doi.org/10.1097/md.0000000000050782}
}

RIS

TY  - JOUR
TI  - Serum FAM19A5 in newly diagnosed type 2 diabetes mellitus and its association with metabolic and inflammatory parameters
AU  - Halime Seda Küçükerdem
AU  - Giray Bozkaya
AU  - İsmail Demir
PY  - 2026
JO  - Medicine
DO  - 10.1097/md.0000000000050782
UR  - https://doi.org/10.1097/md.0000000000050782
ER  - 

APA

Küçükerdem, H. S., Bozkaya, G., & Demir, İ. (2026). Serum FAM19A5 in newly diagnosed type 2 diabetes mellitus and its association with metabolic and inflammatory parameters. Medicine. https://doi.org/10.1097/md.0000000000050782

Source records